T Rothhammer, AK Bosserhoff - Pigment Cell Research, 2007 - prsjournal.net Irreversible changes in the DNA sequence, including chromosomal deletions or
amplification, activating or inactivating mutations in genes, have been
implicated in the development and progression of melanoma. However, ... Cited by 22 - Related articles - Cached - BL Direct - All 8 versions
M Pardo, Á García, B Thomas, A Piñeiro, A … - Proteomics, 2005 - interscience.wiley.com We present here the first proteomics analysis of uveal melanoma (UM) cells.
These cells represent a good model for the identification of polypeptide
markers, which could be developed as diagnostic tools. UM is the most ... Cited by 14 - Related articles - All 3 versions
H Yang, HE Grossniklaus - Current Eye Research, 2006 - informahealthcare.com Purpose: To evaluate the combined effect of neoadjuvant intracameral interferon
α -2b and adjuvant low-dose angiostatin in reducing the number of hepatic
micrometastases in a murine model of ocular melanoma. Methods: The ... Cited by 10 - Related articles - BL Direct - All 6 versions
D Sarkar, ES Park, PB Fisher - Cell Death & Differentiation, 2006 - nature.com Type I interferons (IFN- /- ) are capable of suppressing c-myc mRNA expression
by modulating post-transcriptional processing. However, the molecular mechanism
of this phenomenon is poorly understood. We previously established that ... Cited by 9 - Related articles - BL Direct - All 4 versions
NJ Jellinek - Advances in Dermatology, 2005 - Elsevier In this chapter, Dr Jellinek reviews in detail malignant tumors of the nail
unit. Malignancies of the nail unit are rare and therefore may go unrecognized.
He begins by reviewing the anatomy and histology of the nail unit, ... Cited by 5 - Related articles - All 2 versions
WD Patino, J Susa - Advances in Dermatology, 2008 - Elsevier For many years genetic mutations have been known as important in the multistep
theory of oncogenesis. What has become more evident in the last few years,
however, is that alterations in the genome can be made without mutations ... Cited by 1 - Related articles - All 2 versions
AM Lane, KM Egan, D Harmon, A Holbrook, … - Ophthalmology, 2009 - Elsevier Parts of this paper were presented at the 26th annual Macula Society meeting,
February 26 to March 1, 2003, Naples, Florida, the 2003 Retina Society annual
meeting, September 18 to 21, 2003, Chicago, Illinois, and the Aegean Retina ... Related articles - All 2 versions
PB Fisher, D Sarkar - US Patent App. 11/784,096, 2007 - Google Patents US 20080057055A1 (19) United States (12) Patent Application Publication GO) Pub.
NO.: US 2008/0057055 Al Fisher et al. (43) Pub. Date: Mar. 6,2008 (54) OLD-35 AS
AN INFLAMMATORY AGENT (76) Inventors: Paul B. Fisher, Scarsdale, NY (US); ... Related articles - All 4 versions